The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections

NCT00001035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Hepatitis C

Interventions

DRUG: Interferon alfa-2b
DRUG: Zidovudine
DRUG: Zalcitabine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]